A detailed history of Susquehanna International Group, LLP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 33,851 shares of APLT stock, worth $37,236. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,851
Previous 112,919 70.02%
Holding current value
$37,236
Previous $527,000 45.54%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.35 - $8.5 $343,945 - $672,078
-79,068 Reduced 70.02%
33,851 $287,000
Q2 2024

Aug 15, 2024

SELL
$4.04 - $6.37 $1.5 Million - $2.37 Million
-371,966 Reduced 76.71%
112,919 $527,000
Q1 2024

May 07, 2024

SELL
$2.25 - $7.4 $185,760 - $610,944
-82,560 Reduced 14.55%
484,885 $3.3 Million
Q4 2023

Feb 14, 2024

BUY
$1.84 - $3.35 $871,521 - $1.59 Million
473,653 Added 505.0%
567,445 $1.9 Million
Q3 2023

Nov 14, 2023

BUY
$1.26 - $2.77 $118,177 - $259,803
93,792 New
93,792 $233,000
Q4 2022

Feb 14, 2023

SELL
$0.54 - $1.12 $436 - $906
-809 Reduced 3.56%
21,931 $16,000
Q3 2022

Nov 14, 2022

BUY
$0.86 - $1.55 $8,311 - $14,979
9,664 Added 73.91%
22,740 $21,000
Q2 2022

Aug 15, 2022

BUY
$0.76 - $2.64 $9,937 - $34,520
13,076 New
13,076 $12,000
Q1 2022

May 16, 2022

SELL
$1.48 - $6.22 $89,485 - $376,079
-60,463 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$8.77 - $18.29 $74,413 - $155,190
8,485 Added 16.32%
60,463 $541,000
Q3 2021

Nov 15, 2021

SELL
$13.54 - $22.06 $286,804 - $467,274
-21,182 Reduced 28.95%
51,978 $863,000
Q2 2021

Aug 11, 2021

SELL
$14.05 - $25.04 $227,483 - $405,422
-16,191 Reduced 18.12%
73,160 $1.52 Million
Q1 2021

May 17, 2021

BUY
$16.57 - $28.65 $771,333 - $1.33 Million
46,550 Added 108.76%
89,351 $1.68 Million
Q4 2020

Feb 16, 2021

BUY
$15.44 - $24.23 $447,451 - $702,185
28,980 Added 209.68%
42,801 $942,000
Q3 2020

Nov 16, 2020

BUY
$19.43 - $35.36 $268,542 - $488,710
13,821 New
13,821 $287,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $52.8M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.